Mizuho Increases Fortrea (FTRE) PT to $15 Despite Signs of Peaking Healthcare Trends

Fortrea Holdings Inc. (NASDAQ:FTRE) is one of the best young stocks to buy and hold for 3 years. On January 9, Mizuho raised the firm’s price target on Fortrea to $15 from $13, while keeping a Neutral rating on the shares. In its Q4 2025 preview for healthcare facilities and managed care, Mizuho adjusted its price targets following a physician survey that showed a sequential slowdown in healthcare utilization. Despite facing easier comparisons from the previous year, the decelerating growth suggested that the peak of the utilization trend may have already passed.

Additionally, on January 8, Truist also upgraded Fortrea from Hold to Buy, setting a new price target of $22. The firm’s decision is based on the company’s enhanced operational performance under its new leadership, emerging commercial strength, and a more transparent route toward improving profit margins. Truist believes investor confidence is growing as the CEO prioritizes commercial success, streamlined operations, and stricter financial management.

On January 6, as well, Evercore ISI upgraded Fortrea Holdings Inc. (NASDAQ:FTRE) from In Line to Outperform and significantly raised its price target to $25 from $14. The firm pointed to an accelerating biopharma cycle and the company’s own improved execution as the primary drivers for the upgrade. The firm noted that Fortrea is currently delivering revenue and margins that exceed market expectations while simultaneously benefiting from its efforts to reduce debt.

Fortrea Holdings Inc. (NASDAQ:FTRE) is a contract research organization that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotech, and medical device customers worldwide.

While we acknowledge the potential of FTRE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.